{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,30]],"date-time":"2025-11-30T22:01:53Z","timestamp":1764540113439},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2014,9,14]],"date-time":"2014-09-14T00:00:00Z","timestamp":1410652800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1007\/s00520-014-2406-x","type":"journal-article","created":{"date-parts":[[2014,9,13]],"date-time":"2014-09-13T03:43:25Z","timestamp":1410579805000},"page":"841-849","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["GWAS of 972 autologous stem cell recipients with multiple myeloma identifies 11 genetic variants associated with chemotherapy-induced oral mucositis"],"prefix":"10.1007","volume":"23","author":[{"given":"Elizabeth Ann","family":"Coleman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeannette Y.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen W.","family":"Erickson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia A.","family":"Goodwin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naveen","family":"Sanathkumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinay R.","family":"Raj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daohong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kent D.","family":"McKelvey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Senu","family":"Apewokin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Owen","family":"Stephens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carol A.","family":"Enderlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annette Juul","family":"Vangsted","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patty J.","family":"Reed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elias J.","family":"Anaissie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,9,14]]},"reference":[{"issue":"1","key":"2406_CR1","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1182\/blood-2003-04-1045","volume":"103","author":"B Barlogie","year":"2004","unstructured":"Barlogie B, Shaughnessy J, Tricot G et al (2004) Treatment of multiple myeloma. Blood 103(1):20\u201332. doi: 10.1182\/blood-2003-04-1045","journal-title":"Blood"},{"issue":"7","key":"2406_CR2","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1182\/blood-2002-10-3250","volume":"102","author":"S Giralt","year":"2003","unstructured":"Giralt S, Bensinger W, Goodman M et al (2003) 166Ho-DOTMP plus melphalan followed by peripheral blood stem cell transplantation in patients with multiple myeloma: results of two phase 1\/2 trials. Blood 102(7):2684\u20132691. doi: 10.1182\/blood-2002-10-3250","journal-title":"Blood"},{"issue":"9","key":"2406_CR3","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1200\/JCO.2007.13.6028","volume":"26","author":"N Blijlevens","year":"2008","unstructured":"Blijlevens N, Schwenkglenks M, Bacon P et al (2008) Prospective oral mucositis audit: oral mucositis in patients receiving high-dose melphalan or BEAM conditioning chemotherapy. European Blood and Marrow Transplantation Mucositis Advisory Group. J Clin Oncol 26(9):1519\u20131525. doi: 10.1200\/JCO.2007.13.6028","journal-title":"J Clin Oncol"},{"key":"2406_CR4","volume":"8","author":"JE Clarkson","year":"2010","unstructured":"Clarkson JE, Worthington HV, Furness S et al (2010) Interventions for treating oral mucositis for patients with cancer receiving treatment. Cochrane Database Syst Rev 8, CD001973. doi: 10.1002\/14651858.CD001973.pub4","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"2406_CR5","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/bmt.2008.299","volume":"43","author":"S McCann","year":"2009","unstructured":"McCann S, Schwenkglenks M, Bacon P et al (2009) The prospective oral mucositis audit: relationship of severe oral mucositis with clinical and medical resource use outcomes in patients receiving high-dose melphalan or BEAM-conditioning chemotherapy and autologous SCT. Bone Marrow Transplant 43(2):141\u2013147. doi: 10.1038\/bmt.2008.299","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"2406_CR6","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.idc.2007.03.003","volume":"21","author":"JB Epstein","year":"2007","unstructured":"Epstein JB (2007) Mucositis in the cancer patient and immunosuppressed host. Infect Dis Clin North Am 21(2):503\u2013522. doi: 10.1016\/j.idc.2007.03.003 , vii","journal-title":"Infect Dis Clin North Am"},{"issue":"5","key":"2406_CR7","doi-asserted-by":"crossref","first-page":"784","DOI":"10.3748\/wjg.v19.i5.784","volume":"19","author":"SK Sharma","year":"2013","unstructured":"Sharma SK, Handoo A, Choudhary D, Dhamija G, Gupta N (2013) Severe gastrointestinal mucositis following high dose melphalan therapy for multiple myeloma. World J Gastroenterol 19(5):784\u2013785. doi: 10.3748\/wjg.v19.i5.784 , PMCID: PMC3574610. http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3574610\/pdf\/WJG-19-784.pdf","journal-title":"World J Gastroenterol"},{"issue":"9 Suppl 4","key":"2406_CR8","first-page":"13","volume":"5","author":"BA Murphy","year":"2007","unstructured":"Murphy BA (2007) Clinical and economic consequences of mucositis induced by chemotherapy and\/or radiation therapy. J Support Oncol 5(9 Suppl 4):13\u201321, http:\/\/www.oncologypractice.com\/jso\/journal\/articles\/0509s413.pdf","journal-title":"J Support Oncol"},{"issue":"5","key":"2406_CR9","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/bmt.2008.168","volume":"42","author":"P Tsirigotis","year":"2008","unstructured":"Tsirigotis P, Triantafyllou K, Girkas K et al (2008) Keratinocyte growth factor is effective in the prevention of intestinal mucositis in patients with hematological malignancies treated with high-dose chemotherapy and autologous hematopoietic SCT: a video-capsule endoscopy study. Bone Marrow Transplant 42(5):337\u2013343. doi: 10.1038\/bmt.2008.168","journal-title":"Bone Marrow Transplant"},{"issue":"7","key":"2406_CR10","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/sj.bmt.1705471","volume":"38","author":"ML Grazziutti","year":"2006","unstructured":"Grazziutti ML, Dong L, Miceli MH et al (2006) Oral mucositis in myeloma patients undergoing melphalan-based autologous stem cell transplantation: incidence, risk factors and a severity predictive model. Bone Marrow Transplant 38(7):501\u2013506. doi: 10.1038\/sj.bmt.1705471","journal-title":"Bone Marrow Transplant"},{"issue":"10","key":"2406_CR11","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1056\/NEJMoa053583","volume":"354","author":"B Barlogie","year":"2006","unstructured":"Barlogie B, Tricot G, Anaissie E et al (2006) Thalidomide and hematopoetic-cell transplantation for multiple myeloma. N Engl J Med 354(10):1021\u20131030. doi: 10.1056\/NEJMoa053583","journal-title":"N Engl J Med"},{"issue":"2","key":"2406_CR12","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1365-2141.2007.06639.x","volume":"138","author":"B Barlogie","year":"2007","unstructured":"Barlogie B, Anaissie E, van Rhee F et al (2007) Incorporating bortezomib into upfront treatment for multiple myeloma: early results of Total Therapy 3. Br J Haematol 138(2):176\u2013185. doi: 10.1111\/j.1365-2141.2007.06639.x","journal-title":"Br J Haematol"},{"issue":"21","key":"2406_CR13","volume":"116","author":"EJ Anaissie","year":"2010","unstructured":"Anaissie EJ et al (2010) Comparing toxicities and survival outcomes with total therapy 4 (TT4) for 70-gene (R70)-defined low-risk multiple myeloma (MM) to results obtained with Total Therapy 3 Protocols TT3A and TT3B. Blood (ASH Annu Meet Abstr) 116(21), Abstract 368, http:\/\/abstracts.hematologylibrary.org\/cgi\/content\/abstract\/116\/21\/368?maxtoshow=&hits=10&RESULTFORMAT=&fulltext=368+&searchid=1&FIRSTINDEX=0&volume=116&issue=21&resourcetype=HWCIT","journal-title":"Blood (ASH Annu Meet Abstr)"},{"issue":"17","key":"2406_CR14","first-page":"1098","volume":"317","author":"RD Mosteller","year":"1987","unstructured":"Mosteller RD (1987) Simplified calculation of body surface area. N Engl J Med 317(17):1098. doi: 10.1056\/NEJM198710223171717","journal-title":"N Engl J Med"},{"key":"2406_CR15","unstructured":"Common Terminology Criteria for Adverse Events (CTCAE) version 4. http:\/\/www.acrin.org\/Portals\/0\/Administration\/Regulatory\/CTCAE_4.02_2009-09-15_QuickReference_5x7.pdf"},{"key":"2406_CR16","first-page":"A0828","volume":"11","author":"AS Levey","year":"2000","unstructured":"Levey AS, Greene T, Kusek JW et al (2000) A simplified equation to predict glomerular filtration rate from serum creatinine [abstract]. J Am Soc Nephrol 11:A0828, 155A","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"2406_CR17","doi-asserted-by":"crossref","first-page":"417","DOI":"10.2307\/3001616","volume":"10","author":"WG Cochran","year":"1954","unstructured":"Cochran WG (1954) Some methods for strengthening the common chi-squared tests. Biometrics (Int Biom Soc) 10(4):417\u2013451. doi: 10.2307\/3001616","journal-title":"Biometrics (Int Biom Soc)"},{"issue":"3","key":"2406_CR18","doi-asserted-by":"crossref","first-page":"375","DOI":"10.2307\/3001775","volume":"11","author":"P Armitage","year":"1955","unstructured":"Armitage P (1955) Tests for linear trends in proportions and frequencies. Biometrics (Int Biom Soc) 11(3):375\u2013386. doi: 10.2307\/3001775","journal-title":"Biometrics (Int Biom Soc)"},{"issue":"1","key":"2406_CR19","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamimi","year":"1995","unstructured":"Benjamimi Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. JR Stat Soc B 57(1):289\u2013300, http:\/\/www.jstor.org\/stable\/2346101","journal-title":"JR Stat Soc B"},{"issue":"7385","key":"2406_CR20","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/nature10887","volume":"482","author":"M Guttman","year":"2012","unstructured":"Guttman M, Rinn JL (2012) Modular regulatory principles of large non-coding RNAs. Nature 482(7385):339\u2013346. doi: 10.1038\/nature10887","journal-title":"Nature"},{"issue":"2","key":"2406_CR21","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/humu.22239","volume":"34","author":"G Chen","year":"2013","unstructured":"Chen G, Qiu C, Zhang Q et al (2013) Genome-wide analysis of human SNPs at long intergenic noncoding RNAs. Hum Mutat 34(2):338\u2013344. doi: 10.1002\/humu.22239","journal-title":"Hum Mutat"},{"issue":"7","key":"2406_CR22","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/odi.12146","volume":"19","author":"ST Sonis","year":"2013","unstructured":"Sonis ST, Antin JH, Tedaldi MW, Alterovitz G (2013) SNP-based Bayesian networks can predict oral mucositis risk in autologous stem cell transplant recipients. Oral Dis 19(7):721\u2013727. doi: 10.1111\/odi.12146","journal-title":"Oral Dis"},{"issue":"7","key":"2406_CR23","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/CAD.0b013e3283462086","volume":"22","author":"ST Sonis","year":"2011","unstructured":"Sonis ST (2011) Oral mucositis. Anti Cancer Drugs 22(7):607\u2013612. doi: 10.1097\/CAD.0b013e3283462086","journal-title":"Anti Cancer Drugs"},{"issue":"1","key":"2406_CR24","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1365-2133.1997.tb03695.x","volume":"137","author":"SL Haynes","year":"1997","unstructured":"Haynes SL, Shuttleworth CA, Kielty CM (1997) Keratinocytes express fibrillin and assemble microfibrils: implications for dermal matrix organization. Br J Dermatol 137(1):17\u201323. doi: 10.1046\/j.1365-2133.1997.1762185.x","journal-title":"Br J Dermatol"},{"issue":"4","key":"2406_CR25","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.ymgme.2012.07.023","volume":"107","author":"MR Davis","year":"2012","unstructured":"Davis MR, Summers KM (2012) Structure and function of the mammalian fibrillin gene family: Implications for human connective tissue diseases. Mol Genet Metab 107(4):635\u2013647. doi: 10.1016\/j.ymgme.2012.07.023","journal-title":"Mol Genet Metab"},{"issue":"6","key":"2406_CR26","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1083\/jcb.201003089","volume":"190","author":"H Nistala","year":"2010","unstructured":"Nistala H, Lee-Arteaga S, Smaldone S et al (2010) Fibrillin-1 and -2 differently modulate endogenous TGF-\u03b2 and BMP bioavailability during bone formation. J Cell Biol 190(6):1107\u20131121. doi: 10.1083\/jcb.201003089","journal-title":"J Cell Biol"},{"issue":"9","key":"2406_CR27","doi-asserted-by":"crossref","first-page":"e45221","DOI":"10.1371\/journal.pone.0045221","volume":"7","author":"S Ben-Lulu","year":"2012","unstructured":"Ben-Lulu S, Pollak Y, Mogilner J et al (2012) Dietary transforming growth factor-beta 2 (TGF-\u03b22) supplementation reduces methotrexate-induced intestinal mucosal injury in a rat. PLoS One 7(9):e45221. doi: 10.1371\/journal.pone.0045221","journal-title":"PLoS One"},{"issue":"5","key":"2406_CR28","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1002\/pbc.20910","volume":"48","author":"BAE Koning de","year":"2007","unstructured":"de Koning BAE, Philipsen-Geerling B, Hoijer M et al (2007) Protection against chemotherapy induced mucositis by TGF-\u03b22 in childhood cancer patients: results from a randomized cross-over study. Pediatr Blood Cancer 48(5):532\u2013539. doi: 10.1002\/pbc.20910","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"2406_CR29","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/00002371-200107000-00014","volume":"24","author":"MC Foncuberta","year":"2001","unstructured":"Foncuberta MC, Cagnoni PJ, Brandts CH et al (2001) Topical transforming growth factor TGF-\u03b23 in the prevention or alleviation of chemotherapy-induced oral mucositis in patients with lymphomas or solid tumors. J Immunother 24(4):384\u2013388. doi: 10.1097\/00002371-200107000-00014","journal-title":"J Immunother"},{"issue":"4","key":"2406_CR30","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/nm.3118","volume":"19","author":"HG Bian","year":"2013","unstructured":"Bian HG, Li LF et al (2013) Preventive and therapeutic effects of Smad7 on radiation-induced oral mucositis. Nat Med 19(4):421\u2013428. doi: 10.1038\/nm.3118","journal-title":"Nat Med"},{"issue":"6","key":"2406_CR31","first-page":"1489","volume":"152","author":"VJ Uitto","year":"1998","unstructured":"Uitto VJ, Airola K, Vaalamo M et al (1998) Collagenase-3 (matrix metalloproteinase-13) expression is induced in oral mucosal epithelium during chronic inflammation. Am J Pathol 152(6):1489\u20131499, PMC1858431","journal-title":"Am J Pathol"},{"issue":"2","key":"2406_CR32","doi-asserted-by":"crossref","first-page":"533","DOI":"10.2353\/ajpath.2009.081080","volume":"175","author":"N Hattori","year":"2009","unstructured":"Hattori N, Mochizuki S, Kishi K et al (2009) MMP-13 plays a role in keratinocyte migration, angiogenesis, and contraction in mouse skin wound healing. Am J Pathol 175(2):533\u2013546. doi: 10.2353\/ajpath.2009.081080","journal-title":"Am J Pathol"},{"issue":"8","key":"2406_CR33","doi-asserted-by":"crossref","first-page":"e42596","DOI":"10.1371\/journal.pone.0042596","volume":"7","author":"M Toriseva","year":"2012","unstructured":"Toriseva M, Laato M, Carpen O et al (2012) MMP-13 regulates growth of wound granulation tissue and modulates gene expression signatures involved in inflammation, proteolysis, and cell viability. PLoS One 7(8):e42596. doi: 10.1371\/journal.pone.0042596","journal-title":"PLoS One"},{"issue":"12","key":"2406_CR34","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.2217\/pgs.09.134","volume":"10","author":"N Pinto","year":"2009","unstructured":"Pinto N, Ludeman SM, Dolan ME (2009) Drug focus: pharmacogenetic studies related to cyclophosphamide-based therapy. Pharmacogenomics 10(12):1897\u20131903. doi: 10.2217\/pgs.09.134","journal-title":"Pharmacogenomics"},{"issue":"1","key":"2406_CR35","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2217\/pgs.12.185","volume":"14","author":"M Hassan","year":"2013","unstructured":"Hassan M, Andersson BS (2013) Role of pharmacogenetics in busulfan\/cyclophosphamide conditioning therapy prior to hematopoietic stem cell transplantation. Pharmacogenomics 14(1):75\u201387. doi: 10.2217\/pgs.12.185","journal-title":"Pharmacogenomics"},{"issue":"1","key":"2406_CR36","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/eurjhf\/hfr152","volume":"14","author":"B Lu","year":"2012","unstructured":"Lu B, Tigchelaar W, Ruifrok W et al (2012) DHRS7c, a novel cardiomyocyte-expressed gene that is down-regulated by adrenergic stimulation and in heart failure. Eur J Heart Fail 14(1):5\u201313. doi: 10.1093\/eurjhf\/hfr152","journal-title":"Eur J Heart Fail"},{"issue":"11","key":"2406_CR37","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1001\/jama.299.11.1335","volume":"299","author":"TA Pearson","year":"2008","unstructured":"Pearson TA, Manolio TA (2008) How to interpret a genome-wide association study. JAMA 299(11):1335\u20131344. doi: 10.1001\/jama.299.11.1335","journal-title":"JAMA"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-014-2406-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00520-014-2406-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-014-2406-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,2]],"date-time":"2024-06-02T13:14:48Z","timestamp":1717334088000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00520-014-2406-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,14]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["2406"],"URL":"https:\/\/doi.org\/10.1007\/s00520-014-2406-x","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,14]]}}}